Speaker illustration

Doctor Anna Oleksiak

National Institute of Cardiology, Warsaw (Poland)

Member of:

Blood iron level and vulnerable coronary atherosclerotic plaques.

Event: ACVC 2021

Topic: Vulnerable Plaque

Session: ePoster session

Thumbnail

Quantitative evaluation of regadenoson dynamic computed tomography myocardial perfusion in patients with intermediate coronary artery stenoses in reference to magnetic resonance perfusion imaging.

Event: ESC CONGRESS 2019

Topic: Computed Tomography Myocardial Perfusion

Session: Computed Tomography - Fractional Flow Reserve and Computed Tomography perfusion

Thumbnail

Feasibility of low - dose protocol for regadenoson dynamic computed tomography myocardial perfusion in reference to magnetic resonance myocardial perfusion imaging.

Event: ESC CONGRESS 2019

Topic: Radiation Exposure

Session: Computed Tomography - Fractional Flow Reserve and Computed Tomography perfusion

Thumbnail

Non-standard therapy for end-stage heart failure may change the qualification for heart transplantation.

Event: Acute Cardiovascular Care 2019

Topic: Treatment

Session: Acute Heart Failure - Clinical Cases

Thumbnail

Assessment of myocardial perfusion using dynamic dual source computed tomography in patients with anatomically intermediate coronary artery stenoses.

Event: EuroEcho-Imaging 2017

Topic: Computed Tomography

Session: The additional role of Nuclear Cardiology/Computed Tomography imaging in difficult patients

Thumbnail

ESC 365 is supported by

logo Novo Nordisk